Insulet Corp. Daily Stock Analysis

Daily Stock Analysis, PODD, Insulet Corp, priceseries

Insulet Corp. Daily Stock Analysis
Stock Information
Open
261.21
Close
261.86
High
264.69
Low
255.52
Previous Close
261.71
Daily Price Gain
0.15
YTD High
282.87
YTD High Date
Jan 4, 2022
YTD Low
193.70
YTD Low Date
Jan 27, 2022
YTD Price Change
-13.84
YTD Gain
-5.02%
52 Week High
324.81
52 Week High Date
Nov 10, 2021
52 Week Low
193.70
52 Week Low Date
Jan 27, 2022
52 Week Price Change
25.91
52 Week Gain
10.98%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 9. 2017
38.29
Jan 23. 2017
41.66
9 Trading Days
8.81%
Link
LONG
Jun 12. 2017
43.84
Jun 28. 2017
47.50
12 Trading Days
8.35%
Link
LONG
May 23. 2018
89.16
Jun 15. 2018
96.31
16 Trading Days
8.02%
Link
LONG
Aug 16. 2018
88.03
Sep 17. 2018
103.81
21 Trading Days
17.92%
Link
LONG
Nov 6. 2019
159.99
Dec 3. 2019
178.87
18 Trading Days
11.80%
Link
LONG
Jan 8. 2020
176.95
Feb 24. 2020
206.88
31 Trading Days
16.91%
Link
LONG
Apr 8. 2020
175.87
Apr 28. 2020
191.69
13 Trading Days
8.99%
Link
LONG
Apr 5. 2021
269.12
Apr 19. 2021
285.10
10 Trading Days
5.94%
Link
LONG
Jan 28. 2022
230.59
Feb 14. 2022
245.96
11 Trading Days
6.67%
Link
Company Information
Stock Symbol
PODD
Exchange
NasdaqGS
Company URL
http://www.myomnipod.com
Company Phone
978-600-7000
CEO
Patrick J. Sullivan
Headquarters
Massachusetts
Business Address
600 TECHNOLOGY PARK, SUITE 200, BILLERICA, MA 01821
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001145197
About

Insulet Corp. is an innovative medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It's current product offering consists of diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Billerica, MA.

Description

Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading